Comparison 9. Fractional carbon dioxide (CO₂) laser versus intralesional Triamcinolone acetonide (TAC).

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
9.1 Incidence of treatment‐related adverse effects (24 weeks)	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
9.1.1 Pain at injection site	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
9.1.2 Telangiectasia	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
9.1.3 Skin atrophy	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
9.1.4 Charring	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
9.2 Scar size, colour, height, length, width and pliability, skin surface texture, pruritus and pain (12 weeks)	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
9.2.1 Height (12 weeks)	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
9.2.2 Vascularity (12 weeks)	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
9.2.3 Pliability (12 weeks)	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
9.3 Scar size, colour, height, length, width and pliability, skin surface texture, pruritus and pain (24 weeks)	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
9.3.1 Pigmentation (24 weeks)	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected